Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients

NCT05936606 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

3434

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Clopidogrel monotherapy
DRUG: Tailored anti-platelet therapy

Sponsor

Yonsei University